<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">

Neurodegeneration Screening Assay

Screening compounds for their degeneration index. 


Speak with a scientist

Rapid In vitro screening for degeneration


These in vitro screening assays utilize primary neurons from immature mice or rats. Following the conditioning phase, cultures are treated with compounds and evaluated for their neurodegeneration index. The assays are ideal for screening compounds prior to efficacy in in vivo studies. 

A hallmark of degeneration is the blebbing of neurites, which is when neurites begin disassembly and degeneration. The neurodegeneration index (NI) compares the relative area of neurites and the number of blebs. 


Neurodegeneration Screening Assays

Scientific Data

Staining shows Neurodegeneration following exposure to chemotherapeutic agent, observed by the reduction in neurite area. 

After 5 days of conditioning, there is an appearance of blebs. When the test item is added to the culture, the blebs decrease.

CIPN Screening Assay
Review the complete dataset.

Neurodegeneration Datasheet


Download datasheet


If you are ready to discuss how a partnership can fit into your development program, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can rely on predictive preclinical data.

Request Proposal